|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 914.65 INR | +1.98% |
|
-2.54% | +0.03% |
| Feb. 27 | Zydus Lifesciences says successful clinical development of pembrolizumab biosimilar fyb206 | RE |
| Feb. 26 | Zydus Lifesciences Plans Semaglutide Launch Post Patent Expiry | MT |
Trading Ideas
Search
No results for this search
Select your edition
All financial news and data tailored to specific country editions
